Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Weller Michael and Butowski Nicholas and Tran David D. and Recht Lawrence D. and Lim Michael and Hirte Hal and Ashby Lynn and Mechtler László and Goldlust Samuel A. and Iwamoto Fabio and Drappatz Jan and O’Rourke Donald M. and Wong Mark and Hamilton Mark G. and Hideghéty Katalin (kollab. közrem.): Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
LANCET ONCOLOGY, 18 (10). pp. 1373-1385. ISSN 1470-2045 (2017)

[thumbnail of 1_s2.0_S147020451730517X_main_u.pdf]
Preview
Text
1_s2.0_S147020451730517X_main_u.pdf - Published Version

Download (476kB) | Preview
Item Type: Journal Article
Szerzők száma: 168
Journal or Publication Title: LANCET ONCOLOGY
Date: 2017
Volume: 18
Number: 10
Page Range: pp. 1373-1385
ISSN: 1470-2045
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 3333369
DOI azonosító: https://doi.org/10.1016/S1470-2045(17)30517-X
Date Deposited: 2018. Feb. 12. 15:00
Last Modified: 2020. Mar. 27. 23:15
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12926
Web of Science® Times Cited: 665 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year